论文信息 - Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD)

Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD)

Background Increasingly, genetic specimens are collected to expand the value of clinical trials through study of genetic effects on disease incidence, progression or response to interventions. Purpose and methods We describe the experience obtaining IRB-approved DNA consent forms across the 19 institutions in the Action for Health in Diabetes (Look AHEAD), a clinical trial examining the effect of a lifestyle intervention for weight loss on the risk of serious cardiovascular events among individuals with type 2 diabetes. We document the rates participants provided consent for DNA research, identify participant characteristics associated with consent, and discuss implications for genetics research. Results IRB approval to participate was obtained from 17 of 19 institutions. The overall rate of consent was 89.6% among the 15 institutions that had completed consenting at the time of our analysis, which was higher than reported for other types of cohort studies. Consent rates were associated with factors expected to be associated with weight loss and cardiovascular disease and to affect the distribution of candidate genes. Non-consent occurred more frequently among participants grouped as African-American, Hispanic, female, more highly educated or not dyslipidemic. Limitations The generalizabilty of results is limited by the inclusion/exclusion criteria of the trial. Conclusions Barriers to obtaining consent to participate in genetic studies may differ from other recruitment settings. Because of the potentially complex associations between personal characteristics related to adherence, outcomes and gene distributions, differential rates of consent may introduce biases in estimates of genetic relationships.

[1] Karen C Johnson,et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.

[2] M. Andrew,et al. A community-driven model of research participation: the Jackson Heart Study Participant Recruitment and Retention Study. , 2003, Ethnicity & disease.

[3] R. Kington,et al. Consent for genetic research in a general population: The NHANES experience , 2003, Genetics in Medicine.

[4] Roderick J. A. Little,et al. Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[5] L. Kozlowski,et al. Using a telephone survey to acquire genetic and behavioral data related to cigarette smoking in "made-anonymous" and "registry" samples. , 2002, American journal of epidemiology.

[6] Harry Greenberg,et al. Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. , 2002, Controlled clinical trials.

[7] Charles F Lynch,et al. Racial differences in factors that influence the willingness to participate in medical research studies. , 2002, Annals of epidemiology.

[8] N. Rothman,et al. Factors associated with refusal to provide a buccal cell sample in the Agricultural Health Study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9] M. Cappelli,et al. Participation rates of Ashkenazi Jews in a colon cancer community‐based screening/prevention study , 2002, Clinical genetics.

[10] W. Poston,et al. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials , 2002, International Journal of Obesity.

[11] M Gwinn,et al. Informed consent for population-based research involving genetics. , 2001, JAMA.

[12] Camara P Jones,et al. Invited commentary: "race," racism, and the practice of epidemiology. , 2001, American journal of epidemiology.

[13] A M Nomura,et al. Feasibility of collecting buccal cell DNA by mail in a cohort study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14] G Molenberghs,et al. Bias in estimating association parameters for longitudinal binary responses with drop-outs. , 2001, Biometrics.

[15] B V Howard,et al. Recruitment of American Indians in epidemiologic research: the Strong Heart Study. , 2000, American Indian and Alaska native mental health research.

[16] S. Melamed,et al. Healthy volunteer effect in industrial workers. , 1999, Journal of clinical epidemiology.

[17] Dafydd Gibbon,et al. 1 User’s guide , 1998 .

[18] D. Hunninghake,et al. Recruitment for controlled clinical trials: literature summary and annotated bibliography. , 1997, Controlled clinical trials.

[19] S. Lipsitz,et al. Regression analysis with missing covariate data using estimating equations. , 1996, Biometrics.

[20] W. L. Beeson,et al. Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study. , 1996, Journal of clinical epidemiology.

[21] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[22] B. Rimer,et al. Participation in a women's breast cancer risk counseling trial: Who participates? Who declines? , 1996, Cancer.

[23] J. Bigger,et al. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. , 1996, Controlled clinical trials.

[24] L M Kopelman,et al. Informed consent for genetic research on stored tissue samples. , 1995, JAMA.

[25] W. El-Sadr,et al. The challenge of minority recruitment in clinical trials for AIDS. , 1992, JAMA.

[26] D. Rubin,et al. Statistical Analysis with Missing Data. , 1989 .